# Abortive Treatment of Migraine With the Cefaly® Abortive Program Device

> **NCT03217968** · NA · COMPLETED · sponsor: **Cefaly Technology** · enrollment: 59 (actual)

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Cefaly® Abortive Program device

## Key facts

- **NCT ID:** NCT03217968
- **Lead sponsor:** Cefaly Technology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-10
- **Primary completion:** 2018-01-10
- **Final completion:** 2018-01-10
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03217968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03217968, "Abortive Treatment of Migraine With the Cefaly® Abortive Program Device". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03217968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*